EP Patent

EP1541100A1 — T-shaped intrauterine device and system

Assigned to Familplan Consulting Ltd Oy · Expires 2005-06-15 · 21y expired

What this patent protects

The invention relates to a frame (1) of an intrauterine system consisting of an elongate member (2) having at its first end (3) a transverse member comprising a first wing (4) and a second wing (5), first ends of said wings (4,5) being attached to said elongate member (2). Accord…

USPTO Abstract

The invention relates to a frame (1) of an intrauterine system consisting of an elongate member (2) having at its first end (3) a transverse member comprising a first wing (4) and a second wing (5), first ends of said wings (4,5) being attached to said elongate member (2). According to the invention, said first and second wings (4,5) are symmetrically bent towards a second end (6) of said elongate member (2) so that an angle α formed between said elongate member (2) and said first or second wing (4,5) is 10°-60° and in that the second ends (7,8) of the wings (4,5) are symmetrically bent towards the elongate member (2) by an angle β that is 40°-140°.

Drugs covered by this patent

Patent Metadata

Patent number
EP1541100A1
Jurisdiction
EP
Classification
—
Expires
2005-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Familplan Consulting Ltd Oy
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.